Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet.
Osborne
Raymond
R
Division of Gynecologic Oncology, Toronto-Sunnybrook Regional Cancer Centre, University of Toronto, 2075 Bayview Avenue, Toronto, Ontario M4R 1K6, Canada.
Covens
Allan
A
Mirchandani
D
D
Merchandani
D E
DE
Gerulath
Alan
A
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002822:Choriocarcinoma / Q000188:drug therapy* / Q000473:pathology* / Q000601:surgery; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D031901:Gestational Trophoblastic Disease / Q000188:drug therapy* / Q000473:pathology* / Q000601:surgery; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology; D017239:Paclitaxel / Q000008:administration & dosage; D011247:Pregnancy; D016879:Salvage Therapy; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000473:pathology* / Q000601:surgery
D005047:Etoposide; D017239:Paclitaxel; D002945:Cisplatin